A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
Clinical trial NCT03345979 · COMPLETED
Trial details
- NCT number
- NCT03345979
- Sponsor
- Alkermes, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2019-03-12
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.